Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Infection and Immunity
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions

vaccine

  • <em>Chlamydia</em>-Specific IgA Secretion in the Female Reproductive Tract Induced via Per-Oral Immunization Confers Protection against Primary <em>Chlamydia</em> Challenge
    Microbial Immunity and Vaccines | Spotlight
    Chlamydia-Specific IgA Secretion in the Female Reproductive Tract Induced via Per-Oral Immunization Confers Protection against Primary Chlamydia Challenge

    Chlamydia trachomatis is an obligate intracellular pathogen that causes sexually transmitted disease. In women, chlamydial infections may cause pelvic inflammatory disease (PID), ectopic pregnancy, and infertility. The role of antibodies in protection against a primary Chlamydia infection is unclear and was a focus of this work. Using the...

    Nita Shillova, Savannah E. Howe, Besmir Hyseni, Deahneece Ridgell, Derek J. Fisher, Vjollca Konjufca
  • Open Access
    Evaluation of the Immunogenicity and Protective Efficacy of an Enterotoxigenic <span class="named-content genus-species" id="named-content-1">Escherichia coli</span> CFA/I Adhesin–Heat-Labile Toxin Chimera
    Microbial Immunity and Vaccines
    Evaluation of the Immunogenicity and Protective Efficacy of an Enterotoxigenic Escherichia coli CFA/I Adhesin–Heat-Labile Toxin Chimera

    Recent efforts to develop an enterotoxigenic Escherichia coli (ETEC) vaccine have focused on the antigenically conserved tip adhesins of colonization factors. We showed previously that intranasal immunization with dsc19CfaE, a soluble variant of the in cis donor strand-complemented tip adhesin of a colonization factor of the class 5 family (CFA/I)...

    Aisling O'Dowd, Milton Maciel, Steven T. Poole, Michael G. Jobling, Julianne E. Rollenhagen, Colleen M. Woods, Stephanie A. Sincock, Annette L. McVeigh, Michael J. Gregory, Ryan C. Maves, Michael G. Prouty, Randall K. Holmes, Stephen J. Savarino
  • Importance of the Immunodominant CD8<sup>+</sup> T Cell Epitope of <span class="named-content genus-species" id="named-content-1">Plasmodium berghei</span> Circumsporozoite Protein in Parasite- and Vaccine-Induced Protection
    Fungal and Parasitic Infections
    Importance of the Immunodominant CD8+ T Cell Epitope of Plasmodium berghei Circumsporozoite Protein in Parasite- and Vaccine-Induced Protection

    The circumsporozoite protein (CSP) builds up the surface coat of sporozoites and is the leading malaria pre-erythrocytic-stage vaccine candidate. CSP has been shown to induce robust CD8+ T cell responses that are capable of eliminating developing parasites in hepatocytes, resulting in protective immunity. In this study, we characterized the importance of the immunodominant CSP-derived epitope SYIPSAEKI of...

    Matthew P. Gibbins, Katja Müller, Maya Glover, Jasmine Liu, Elyzana D. Putrianti, Karolis Bauza, Arturo Reyes-Sandoval, Kai Matuschewski, Olivier Silvie, Julius Clemence R. Hafalla
  • Vaccination with Secreted Aspartyl Proteinase 2 Protein from <em>Candida parapsilosis</em> Can Enhance Survival of Mice during <em>C. tropicalis</em>-Mediated Systemic Candidiasis
    Microbial Immunity and Vaccines
    Vaccination with Secreted Aspartyl Proteinase 2 Protein from Candida parapsilosis Can Enhance Survival of Mice during C. tropicalis-Mediated Systemic Candidiasis

    The rising incidence of non-albicans Candida species globally, along with the emergence of drug resistance, is a cause for concern. This study investigated the protective efficacy of secreted aspartyl proteinase 2 (Sap2) in systemic C. tropicalis infection. Vaccination with recombinant Sap2 (rSap2) protein from...

    Manisha Shukla, Soma Rohatgi
  • Immunization against <span class="named-content genus-species" id="named-content-1">Anaplasma phagocytophilum</span> Adhesin Binding Domains Confers Protection against Infection in the Mouse Model
    Cellular Microbiology: Pathogen-Host Cell Molecular Interactions | Spotlight
    Immunization against Anaplasma phagocytophilum Adhesin Binding Domains Confers Protection against Infection in the Mouse Model

    Anaplasma phagocytophilum causes granulocytic anaplasmosis, a debilitating infection that can be fatal in the immunocompromised. It also afflicts animals, including dogs, horses, and sheep. No granulocytic anaplasmosis vaccine exists. Because A. phagocytophilum is an obligate intracellular bacterium...

    Waheeda A. Naimi, Jacob J. Gumpf, Ryan S. Green, Jerilyn R. Izac, Matthew P. Zellner, Daniel H. Conrad, Richard T. Marconi, Rebecca K. Martin, Jason A. Carlyon
  • Nontypeable <span class="named-content genus-species" id="named-content-1">Haemophilus influenzae</span> Type IV Pilus Mediates Augmented Adherence to Rhinovirus-Infected Human Airway Epithelial Cells
    Bacterial Infections
    Nontypeable Haemophilus influenzae Type IV Pilus Mediates Augmented Adherence to Rhinovirus-Infected Human Airway Epithelial Cells

    Human rhinovirus (hRV) is frequently detected in the upper respiratory tract, and symptomatic infection is associated with an increased nasopharyngeal bacterial load, with subsequent development of secondary bacterial diseases. Nontypeable Haemophilus influenzae (NTHI) is a commensal bacterial species of the human nasopharynx; however, in the context of prior or...

    Stephen L. Toone, Michelle Ratkiewicz, Laura A. Novotny, Binh L. Phong, Lauren O. Bakaletz
  • Progress towards the Development of a NEAT Vaccine for Anthrax II: Immunogen Specificity and Alum Effectiveness in an Inhalational Model
    Microbial Immunity and Vaccines
    Progress towards the Development of a NEAT Vaccine for Anthrax II: Immunogen Specificity and Alum Effectiveness in an Inhalational Model

    Bacillus anthracis is the causative agent of anthrax disease, presents with high mortality, and has been at the center of bioweapon efforts. The only currently U.S. FDA-approved vaccine to prevent anthrax in humans is anthrax vaccine adsorbed (AVA), which is protective in several animal models and induces neutralizing antibodies against protective antigen (PA), the...

    Joseph Jelinski, Austen Terwilliger, Sabrina Green, Anthony Maresso
  • The Factor H-Binding Site of CspZ as a Protective Target against Multistrain, Tick-Transmitted Lyme Disease
    Microbial Immunity and Vaccines
    The Factor H-Binding Site of CspZ as a Protective Target against Multistrain, Tick-Transmitted Lyme Disease

    The spirochete Borrelia burgdorferi sensu lato is the causative agent of Lyme disease (LD). The spirochetes produce the CspZ protein that binds to a complement regulator, factor H (FH). Such binding downregulates activation of host complement to facilitate spirochete evasion of complement killing. However, vaccination with CspZ does not protect against LD...

    Ashley L. Marcinkiewicz, Ilva Lieknina, Xiuli Yang, Patricia L. Lederman, Thomas M. Hart, Jennifer Yates, Wen-Hsiang Chen, Maria Elena Bottazzi, Nicholas J. Mantis, Peter Kraiczy, Utpal Pal, Kaspars Tars, Yi-Pin Lin
  • Broadly Protective Multivalent OspA Vaccine against Lyme Borreliosis, Developed Based on Surface Shaping of the C-Terminal Fragment
    Microbial Immunity and Vaccines | Spotlight
    Broadly Protective Multivalent OspA Vaccine against Lyme Borreliosis, Developed Based on Surface Shaping of the C-Terminal Fragment

    The development of vaccines for prevention of diseases caused by pathogenic species can encounter major obstacles if high sequence diversity is observed between individual strains. Therefore, development might be restricted either to conserved antigens, which are often rare, or to multivalent vaccines, which renders the production more costly and cumbersome. In light of this complexity, we applied a structure-based surface shaping...

    Abhijeet Nayak, Wolfgang Schüler, Stefan Seidel, Ivan Gomez, Andreas Meinke, Pär Comstedt, Urban Lundberg
  • Vaccine-Specific Immune Responses against <span class="named-content genus-species" id="named-content-1">Mycobacterium ulcerans</span> Infection in a Low-Dose Murine Challenge Model
    Microbial Immunity and Vaccines
    Vaccine-Specific Immune Responses against Mycobacterium ulcerans Infection in a Low-Dose Murine Challenge Model

    The neglected tropical disease Buruli ulcer (BU) is an infection of subcutaneous tissue with Mycobacterium ulcerans. There is no effective vaccine. Here, we assessed an experimental prime-boost vaccine in a low-dose murine tail infection model. We used the enoyl reductase (ER) domain of the M. ulcerans...

    Kirstie M. Mangas, Andrew H. Buultjens, Jessica L. Porter, Sarah L. Baines, Estelle Marion, Laurent Marsollier, Nicholas J. Tobias, Sacha J. Pidot, Kylie M. Quinn, David J. Price, Katherine Kedzierska, Weiguang Zeng, David C. Jackson, Brendon Y. Chua, Timothy P. Stinear

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
Back to top

About

  • About IAI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #IAIjournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0019-9567; Online ISSN: 1098-5522